Combination Drugs and Novel Agents Are Driving Market
Increasing prevalence of cardiovascular diseases, increasing aging population, and growing acceptance of minimally invasive endovascular surgeries are expected to drive the market growth during the forecast period.
Program highlighted in new issue of Better Tennessee magazine
Announced by ingenious targeting laboratory
The Expert Network celebrates its newest member, Dr. Vilma I. Torres
Gladstone scientists show that a cancer drug is effective in treating common causes of heart failure
Newest kit innovation expands commitment to continuous vascular access improvements
MASTER-DAPT kicks-off with the enrolment of its first patient by Treant Zorggroep, Scheper Hospital
Deepak Srivastava, MD, led a team who created mouse models of CAVD that may be used to test drug therapies for the disease.
Lower stroke, mortality, renal failure, bleeding, atrial fibrillation, and length of intensive care unit stay with newer no-touch technique
With baby boomers entering into their 60s and 70s, America's doctors are heavily relying on certified hospital technicians to help with our aging population. Because we believe these techs play an important role in meeting the demand of our country's changing demographics, Phlebotomy Online Training Center offers our self-paced Online Telemetry Technician Certification Course for students.
Pulmonary fibrosis (PF) is one of a family of related diseases called interstitial lung diseases that can result in lung scarring. As the lung tissue becomes scarred, it interferes with a person's ability to breathe.
Rod Carew, former Minnesota Twins, Los Angeles Angles of Anaheim, and heart failure survivor teams up with The American Heart Association in an effort to improve the treatment outcomes and the overall experience of heart failure patients.
The Expert Network celebrates its newest member, Dr. Donald E. Jansen
OSTAR Meditech has launched the 'OSTAR P2-The Heart Spectrum Blood Pressure Monitor' project on Indiegogo. The team behind this campaign is crowdfunding to bring an innovative life-saving home medical device to consumers everywhere.
Global study involving 4,300 patients from 34 countries announced at EuroPCR
Cardio Force is a vitamin, mineral, herbal, and enzyme supplement that supports healthy cardiovascular function and is 100 percent natural, vegan, and gluten-free.
Geneticure will explain results from a retrospective study that demonstrate that the patented Geneticure Hypertension Panel significantly reduces the time to achieve optimal blood pressure control and can reduce the number of clinic visits for patients being treated for hypertension.